108 related articles for article (PubMed ID: 23355336)
1. Molecular diagnosis and prognostic significance of lymph node micrometastasis in patients with histologically node-negative non-small cell lung cancer.
Dai CH; Li J; Yu LC; Li XQ; Shi SB; Wu JR
Tumour Biol; 2013 Apr; 34(2):1245-53. PubMed ID: 23355336
[TBL] [Abstract][Full Text] [Related]
2. [Long-term survival of personalized surgical treatment of locally advanced non-small cell lung cancer based on molecular staging].
Zhou Q; Shi Y; Chen J; Liu B; Wang Y; Zhu D; Zhang HT; Xu P; Gong Y; Chen G; Wei S; Qiu X; Niu Z; Chen X; Lei Z; Duan L; Wu Z
Zhongguo Fei Ai Za Zhi; 2011 Feb; 14(2):86-106. PubMed ID: 21342639
[TBL] [Abstract][Full Text] [Related]
3. Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer.
Miura N; Nakamura H; Sato R; Tsukamoto T; Harada T; Takahashi S; Adachi Y; Shomori K; Sano A; Kishimoto Y; Ito H; Hasegawa J; Shiota G
Cancer Sci; 2006 Dec; 97(12):1366-73. PubMed ID: 17052260
[TBL] [Abstract][Full Text] [Related]
4. Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non-Small Cell Lung Cancer.
Smeltzer MP; Faris N; Yu X; Ramirez RA; Ramirez LE; Wang CG; Adair C; Berry A; Osarogiagbon RU
Ann Thorac Surg; 2016 Aug; 102(2):448-53. PubMed ID: 27266421
[TBL] [Abstract][Full Text] [Related]
5. The presence of intraepithelial CD45RO+ cells in resected lymph nodes with metastases from NSCLC patients is an independent predictor of disease-specific survival.
Kilvaer TK; Paulsen EE; Khanehkenari MR; Al-Saad S; Johansen RM; Al-Shibli K; Bremnes RM; Busund LT; Donnem T
Br J Cancer; 2016 May; 114(10):1145-51. PubMed ID: 27167450
[TBL] [Abstract][Full Text] [Related]
6. Identification of nodal micrometastasis in colorectal cancer using deep learning on annotation-free whole-slide images.
Chuang WY; Chen CC; Yu WH; Yeh CJ; Chang SH; Ueng SH; Wang TH; Hsueh C; Kuo CF; Yeh CY
Mod Pathol; 2021 Oct; 34(10):1901-1911. PubMed ID: 34103664
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of lymph node micrometastasis in oral and oropharyngeal cancer: A systematic review.
Liokatis P; Liokati I; Obermeier K; Smolka W; Ersan F; Dewenter I; Otto S; Philipp P; Siegmund B; Walz C; Braunschweig T; Klauschen F; Mock A
Oral Oncol; 2024 Jul; 154():106808. PubMed ID: 38823172
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of non-small cell lung cancer with postoperative regional lymph node recurrence.
Ohtaki Y; Nagashima T; Okano N; Kubo N; Ohtaka T; Sunaga N; Sakurai R; Miura Y; Nakazawa S; Kawatani N; Yazawa T; Yoshikawa R; Narusawa E; Shirabe K
Thorac Cancer; 2024 Apr; 15(11):859-866. PubMed ID: 38414316
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach.
Chang JC; Alex D; Bott M; Tan KS; Seshan V; Golden A; Sauter JL; Buonocore DJ; Vanderbilt CM; Gupta S; Desmeules P; Bodd FM; Riely GJ; Rusch VW; Jones DR; Arcila ME; Travis WD; Ladanyi M; Rekhtman N
Clin Cancer Res; 2019 Dec; 25(23):7113-7125. PubMed ID: 31471310
[TBL] [Abstract][Full Text] [Related]
10. NUF2 Expression in Cancer Tissues and Lymph Nodes Suggests Post-Surgery Recurrence of Non-Small Cell Lung Cancer.
Shirakami C; Ikeda K; Hinokuma H; Nishi W; Shinchi Y; Matsubara E; Osumi H; Fujino K; Suzuki M
Diagnostics (Basel); 2024 Feb; 14(5):. PubMed ID: 38472943
[TBL] [Abstract][Full Text] [Related]
11. Outcomes in Premenopausal Patients with HR+/HER2- Breast Cancer and Lymph Node Micrometastasis Based on the 21-Gene Recurrence Score.
Bilani N; Patel R; Crowley F; Tiersten A
Oncologist; 2023 Dec; 28(12):1049-1054. PubMed ID: 37682780
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the c-MET gene amplification between primary tumor and metastatic lymph nodes in non-small cell lung cancer.
Xu CW; Wang WX; Wu MJ; Zhu YC; Zhuang W; Lin G; Du KQ; Huang YJ; Chen YP; Chen G; Fang MY
Thorac Cancer; 2017 Sep; 8(5):417-422. PubMed ID: 28590585
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance and prospective mechanism of increased CDKN2A expression in small cell lung cancer.
Li DM; Li GS; Li JD; Chen F; Huang H; Huang WY; Huang ZG; Dang YW; Tang YL; Tang ZQ; Tang WJ; Chen G; Lu HP
Clin Transl Oncol; 2024 Jun; 26(6):1519-1531. PubMed ID: 38206516
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of combined pathological responses in primary tumor and lymph nodes following neoadjuvant chemoimmunotherapy in non-small cell lung cancer.
Huang S; Wu J; Li S; Li X; Zeng R; Tang Y; Tang J; Ben X; Zhang D; Xie L; Zhou H; Chen G; Wang S; Gao Z; Wu H; Chen R; Xu F; Qiao G
Lung Cancer; 2023 Dec; 186():107401. PubMed ID: 37844351
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of lymph node metastasis in resected adenosquamous lung cancer.
Kong M; Jin J; Cai X; Shen J; Ma D; Ye M; Zhu C; Freedman S; Walters K; Xu X; Chen B
Medicine (Baltimore); 2017 Dec; 96(48):e8870. PubMed ID: 29310370
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Factors of IIIAN2 Non-Small-Cell Lung Cancer after Complete Resection: A Systemic Review and Meta-analysis.
Wang Y; Wan Y; Qian Y
Comput Math Methods Med; 2021; 2021():1068090. PubMed ID: 34938347
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Necl-5 correlates with unfavorable prognosis in patients with lung adenocarcinoma.
Nakai R; Maniwa Y; Tanaka Y; Nishio W; Yoshimura M; Okita Y; Ohbayashi C; Satoh N; Ogita H; Takai Y; Hayashi Y
Cancer Sci; 2010 May; 101(5):1326-30. PubMed ID: 20331633
[TBL] [Abstract][Full Text] [Related]
18. Surgical intervention paradoxically enhances micrometastasis - targeting perioperative variables.
Selvaraj V; Sekaran S; Rajamani Sekar SK
Int J Surg; 2023 Oct; 109(10):3226-3227. PubMed ID: 37462983
[No Abstract] [Full Text] [Related]
19. Tertiary prevention strategies for micrometastatic lymph node cervical cancer: A systematic review and a prototype of an adapted model of care.
Śniadecki M; Guani B; Jaworek P; Klasa-Mazurkiewicz D; Mahiou K; Mosakowska K; Buda A; Poniewierza P; Piątek O; Crestani A; Stasiak M; Balaya V; Musielak O; Piłat L; Maliszewska K; Aristei C; Guzik P; Wojtylak S; Liro M; Gaillard T; Kocian R; Gołąbiewska A; Chmielewska Z; Wydra D
Crit Rev Oncol Hematol; 2024 May; 197():104329. PubMed ID: 38527594
[TBL] [Abstract][Full Text] [Related]
20. OCIA domain containing 2 is highly expressed in adenocarcinoma mixed subtype with bronchioloalveolar carcinoma component and is associated with better prognosis.
Ishiyama T; Kano J; Anami Y; Onuki T; Iijima T; Morisita Y; Yokota J; Noguchi M
Cancer Sci; 2007 Jan; 98(1):50-7. PubMed ID: 17054434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
